Age correlation with childhood nephrotic syndrome

Background. A common glomerular disease in children, childhood nephrotic syndrome (NS) causes proteinuria, hypoalbuminemia, hyperlipidaemia, and oedema; peak incidence falls between ages 2 and 6. The age at onset greatly affects illness presentation, treatment response, and long-term prognosis; thus, age-specific methods for diagnosis and therapy are rather important. The study matches ages of SSNS children with sociodemographic, clinical, and laboratory characteristics. Method. From January to November 2022, 60 children with steroid-sensitive nephrotic syndrome (SSNS) were studied in Al-Immamain Al-Kadhmain Medical City, Baghdad, Iraq. Interviews, medical records, and physical exams gathered data on demographics, illness features, and clinical parameters; extra blood and urine tests were conducted during relapses. Applying standardised definitions for NS, SSNS, relapse, and other criteria, ethical clearance was obtained before enrolment. Results. While older children (>5 years) had greater blood creatinine and cholesterol levels, suggesting possible variations in disease severity, younger children (<5 years) with nephrotic syndrome (NS) had an earlier illness onset and were more likely to live in urban settings. The absence of any appreciable age-related variations in steroid response, infections, or IgE levels emphasises the necessity of more study to investigate age-specific illness processes. Conclusion. The study revealed variations depending on age between children with nephrotic syndrome (NS). For instance, older children (≥5 years) had greater rates of asthma, elevated blood creatinine and cholesterol levels; younger children (≤5 years) started the disease sooner and resided in cities more commonly. These results highlight the need for age-specific therapy approaches to solve different clinical and metabolic profiles even in cases with similar steroid responses.